Image

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened using a low dose CT scan.

Eligibility

Cohort A:

Inclusion Criteria:

  • Current diagnosis of lung cancer with a driver mutation.
  • Known driver mutation (e.g. via NGS, PCR, IHC, FISH, RT-PCR etc.)
  • Able and willing to give informed consent.
  • Able and willing to complete the screening questionnaire.

Cohort A:

Exclusion Criteria:

  • There are no exclusion criteria for Cohort A.

Cohort B:

Inclusion Criteria:

  • Age 40 - 80.
  • Must have a first degree relative (mother, father, sibling, biological child) eligible for Cohort A. Note: Multiple first degree relatives of a Cohort A eligible participant may be approached for participation into the trial.
  • Smoked < 20 pack years; a. Pack years = numbers of packs per day × number of years smoked; b. One pack year is the equivalent of smoking an average of 20 cigarettes (1 pack) per day for a year.
  • Be able to undergo a low dose chest CT scan.
  • If an upper respiratory infection (pneumonia, COVID19, flu, etc.) occurred in the last 3 months, this infection must have resolved by time of enrollment.
  • Able and willing to provide informed consent.
  • Able and willing to comply with the protocol requirements

Cohort B:

Exclusion Criteria:

  • Previous history of lung cancers.
  • Symptoms suggestive of presence of current lung cancer, including (but not limited to): unexplained weight loss of over 15 pounds within the last 12 months or unexplained hemoptysis.
  • Pregnant at time of enrollment.
  • History of any type of cancer within 5 years, with the exception of in situ carcinomas and non-melanoma skin cancers (if excised).
  • Current smoker.
  • Smoked ≥ 20 pack years.
  • Had a chest CT scan within 1 year of study entry.

Study details
    Lung Cancer
    Driver Mutation

NCT07062172

University of California, Irvine

20 July 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.